Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: Incidence between 2017 and 2019 and patient profiles from 38.6 million people in six European countries

Edward Burn; Xintong Li; Kristin Kostka; Henry Morgan Stewart; Christian Reich; Sarah Seager; Talita Duarte-Salles; Sergio Fernandez-Bertolin; María Aragón; Carlen Reyes; Eugenia Martinez-Hernandez; Edelmira Marti; Antonella Delmestri; Katia Verhamme; Peter Rijnbeek; Scott Horban; Daniel R. Morales; Daniel Prieto-Alhambra

doi:10.1002/pds.5419

Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: Incidence between 2017 and 2019 and patient profiles from 38.6 million people in six European countries

Edward Burn, Xintong Li, Kristin Kostka, Henry Morgan Stewart, Christian Reich, Sarah Seager, Talita Duarte-Salles, Sergio Fernandez-Bertolin, María Aragón, Carlen Reyes, Eugenia Martinez-Hernandez, Edelmira Marti, Antonella Delmestri, Katia Verhamme, Peter Rijnbeek, Scott Horban, Daniel R. Morales, Daniel Prieto-Alhambra^*

^*Corresponding author for this work

Medical Informatics

Research output: Contribution to journal › Article › Academic › peer-review

12 Citations (Scopus)

Original language	English
Pages (from-to)	495-510
Number of pages	16
Journal	Pharmacoepidemiology and Drug Safety
Volume	31
Issue number	5
DOIs	https://doi.org/10.1002/pds.5419
Publication status	Published - May 2022

Bibliographical note

ACKNOWLEDGEMENTS:
This study was funded by the European Medicines Agency in the form of a competitive tender (Lot ROC No EMA/2017/09/PE). The authors acknowledge Prof. Johan Van der Lei for the overall management of this research grant.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/pds.5419

Cite this

Burn, E., Li, X., Kostka, K., Stewart, H. M., Reich, C., Seager, S., Duarte-Salles, T., Fernandez-Bertolin, S., Aragón, M., Reyes, C., Martinez-Hernandez, E., Marti, E., Delmestri, A., Verhamme, K., Rijnbeek, P., Horban, S., Morales, D. R., & Prieto-Alhambra, D. (2022). Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: Incidence between 2017 and 2019 and patient profiles from 38.6 million people in six European countries. Pharmacoepidemiology and Drug Safety, 31(5), 495-510. https://doi.org/10.1002/pds.5419

@article{363749d0ca8a4649a3bb9e7a8a4f576f,

title = "Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: Incidence between 2017 and 2019 and patient profiles from 38.6 million people in six European countries",

author = "Edward Burn and Xintong Li and Kristin Kostka and Stewart, {Henry Morgan} and Christian Reich and Sarah Seager and Talita Duarte-Salles and Sergio Fernandez-Bertolin and Mar{\'i}a Arag{\'o}n and Carlen Reyes and Eugenia Martinez-Hernandez and Edelmira Marti and Antonella Delmestri and Katia Verhamme and Peter Rijnbeek and Scott Horban and Morales, {Daniel R.} and Daniel Prieto-Alhambra",

note = "ACKNOWLEDGEMENTS: This study was funded by the European Medicines Agency in the form of a competitive tender (Lot ROC No EMA/2017/09/PE). The authors acknowledge Prof. Johan Van der Lei for the overall management of this research grant. ",

year = "2022",

month = may,

doi = "10.1002/pds.5419",

language = "English",

volume = "31",

pages = "495--510",

journal = "Pharmacoepidemiology and Drug Safety",

issn = "1053-8569",

publisher = "John Wiley & Sons Ltd.",

number = "5",

}

Burn, E, Li, X, Kostka, K, Stewart, HM, Reich, C, Seager, S, Duarte-Salles, T, Fernandez-Bertolin, S, Aragón, M, Reyes, C, Martinez-Hernandez, E, Marti, E, Delmestri, A, Verhamme, K , Rijnbeek, P, Horban, S, Morales, DR & Prieto-Alhambra, D 2022, 'Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: Incidence between 2017 and 2019 and patient profiles from 38.6 million people in six European countries', Pharmacoepidemiology and Drug Safety, vol. 31, no. 5, pp. 495-510. https://doi.org/10.1002/pds.5419

Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: Incidence between 2017 and 2019 and patient profiles from 38.6 million people in six European countries. / Burn, Edward; Li, Xintong; Kostka, Kristin et al.
In: Pharmacoepidemiology and Drug Safety, Vol. 31, No. 5, 05.2022, p. 495-510.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance

T2 - Incidence between 2017 and 2019 and patient profiles from 38.6 million people in six European countries

AU - Burn, Edward

AU - Li, Xintong

AU - Kostka, Kristin

AU - Stewart, Henry Morgan

AU - Reich, Christian

AU - Seager, Sarah

AU - Duarte-Salles, Talita

AU - Fernandez-Bertolin, Sergio

AU - Aragón, María

AU - Reyes, Carlen

AU - Martinez-Hernandez, Eugenia

AU - Marti, Edelmira

AU - Delmestri, Antonella

AU - Verhamme, Katia

AU - Rijnbeek, Peter

AU - Horban, Scott

AU - Morales, Daniel R.

AU - Prieto-Alhambra, Daniel

N1 - ACKNOWLEDGEMENTS: This study was funded by the European Medicines Agency in the form of a competitive tender (Lot ROC No EMA/2017/09/PE). The authors acknowledge Prof. Johan Van der Lei for the overall management of this research grant.

PY - 2022/5

Y1 - 2022/5

UR - http://www.scopus.com/inward/record.url?scp=85125379490&partnerID=8YFLogxK

U2 - 10.1002/pds.5419

DO - 10.1002/pds.5419

M3 - Article

C2 - 35191114

AN - SCOPUS:85125379490

SN - 1053-8569

VL - 31

SP - 495

EP - 510

JO - Pharmacoepidemiology and Drug Safety

JF - Pharmacoepidemiology and Drug Safety

IS - 5

ER -

Burn E, Li X, Kostka K, Stewart HM, Reich C, Seager S et al. Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: Incidence between 2017 and 2019 and patient profiles from 38.6 million people in six European countries. Pharmacoepidemiology and Drug Safety. 2022 May;31(5):495-510. doi: 10.1002/pds.5419

Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: Incidence between 2017 and 2019 and patient profiles from 38.6 million people in six European countries

Bibliographical note

UN SDGs

Access to Document

Other files and links

Cite this